Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.38 USD | -4.12% |
|
+9.54% | -39.29% |
15/07 | Singular Genomics Regains Nasdaq Compliance | MT |
09/07 | Goldman Sachs Adjusts Price Target on Singular Genomics Systems to $6.50 From $22.50, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.29% | 21.59M | |
+22.15% | 46.55B | |
+45.94% | 41.84B | |
-2.37% | 40.84B | |
+33.84% | 32.95B | |
-6.35% | 28.27B | |
+20.42% | 27.78B | |
+48.83% | 14.26B | |
+45.00% | 13.69B | |
+0.06% | 12.18B |
- Stock Market
- Equities
- OMIC Stock
- News Singular Genomics Systems, Inc.
- Singular Genomics Regains Nasdaq Compliance